δ receptors are required for full inhibitory coupling of μ receptors to voltage-dependent Ca2+ channels in dorsal root ganglion neurons

Molecular Pharmacology

Volumn 76, Issue 1, 2009, Pages 134-143

  Walwyn, Wendy ^a   John, Scott ^b   Maga, Matthew ^a   Evans, Christopher J ^a   Hales, Tim G ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACLOFEN; DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR AGONIST; DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLARGINYLTHREONYLPENICILLAMINYLTHREONINAMIDE 2,7 DISULFIDE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); MESSENGER RNA; MORPHINE; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR AGONIST; VOLTAGE GATED CALCIUM CHANNEL;

ANALGESIC ACTIVITY; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; CELL LINE; CONTROLLED STUDY; DIMERIZATION; DRUG EFFICACY; DRUG POTENCY; ELECTRIC POTENTIAL; FLOW CYTOMETRY; INTERNALIZATION; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINAL GANGLION;

ANIMALS; CALCIUM CHANNELS; DIMERIZATION; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ENKEPHALIN, D-PENICILLAMINE (2,5)-; GANGLIA, SPINAL; MICE; MICE, INBRED C57BL; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, MU;

EID: 67649854846     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.109.055913     Document Type: Article

References (44)

1. Beland B and Fitzgerald M (2001) Mu- and delta-opioid receptors are downregulated in the largest diameter primary sensory neurons during postnatal development in rats. Pain 90:143-150. (Pubitemid 32146567)
2. 3 cells changes the functional response to μ agonists from inhibitory to excitatory. Mol Pharmacol 63:89-95. (Pubitemid 36043812)
3. Chen J, Sochivko D, Beck H, Marechal D, Wiestler OD, and Becker AJ (2001) Activity-induced expression of common reference genes in individual CNS neurons. Lab Invest 81:913-916. (Pubitemid 32553412)
4. Chen YL, Law PY, and Loh HH (2008) The other side of the opioid story: modulation of cell growth and survival signaling. Curr Med Chem 15:772-778.
5. Christie MJ (2008) Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction. Br J Pharmacol 154:384-396. (Pubitemid 351670590)
6. Coop A and Rice KC (2000) Role of δ-opioid receptors in biological processes. Drug News Perspect 13:481-487. (Pubitemid 32063587)
7. Cvejic S and Devi LA (1997) Dimerization of the δ opioid receptor: implication for a role in receptor internalization. J Biol Chem 272:26959-26964.
8. Décaillot FM, Rozenfeld R, Gupta A, and Devi LA (2008) Cell surface targeting of μ-δ opioid receptor heterodimers by RTP4. Proc Natl Acad Sci U S A 105:16045-16050.
9. Dong C, Filipeanu CM, Duvernay MT, and Wu G (2007) Regulation of G proteincoupled receptor export trafficking. Biochim Biophys Acta 1768:853-870. (Pubitemid 46452538)
10. Fan T, Varghese G, Nguyen T, Tse R, O'Dowd BF, and George SR (2005) A role for the distal carboxyl tails in generating the novel pharmacology and G protein activation profile of μ and δ opioid receptor hetero-oligomers. J Biol Chem 280: 38478-38488. (Pubitemid 43853746)
11. Filliol D, Ghozland S, Chluba J, Martin M, Matthes HW, Simonin F, Befort K, Gavériaux-Ruff C, Dierich A, LeMeur M, et al. (2000) Mice deficient for δ- and μ-opioid receptors exhibit opposing alterations of emotional responses. Nat Genet 25:195-200. (Pubitemid 30394992)
12. Gavériaux-Ruff C and Kieffer BL (2002) Opioid receptor genes inactivated in mice: the highlights. Neuropeptides 36:62-71. (Pubitemid 35041867)
13. George SR, Fan T, Xie Z, Tse R, Tam V, Varghese G, and O'Dowd BF (2000) Oligomerization of μ- and δ-opioid receptors. Generation of novel functional properties. J Biol Chem 275:26128-26135. (Pubitemid 30676657)
14. Gomes I, Gupta A, Filipovska J, Szeto HH, Pintar JE, and Devi LA (2004) A role for heterodimerization of μ and δ opiate receptors in enhancing morphine analgesia. Proc Natl Acad Sci U S A 101:5135-5139.
15. Gomes I, Jordan BA, Gupta A, Trapaidze N, Nagy V, and Devi LA (2000) Heterodimerization of μ and δ opioid receptors: a role in opiate synergy. J Neurosci 20:RC110(1-5).
16. Goody RJ, Oakley SM, Filliol D, Kieffer BL, and Kitchen I (2002) Quantitative autoradiographic mapping of opioid receptors in the brain of δ-opioid receptor gene knockout mice. Brain Res 945:9-19. (Pubitemid 34756571)
17. Guan JS, Xu ZZ, Gao H, He SQ, Ma GQ, Sun T, Wang LH, Zhang ZN, Lena I, Kitchen I, et al. (2005) Interaction with vesicle luminal protachykinin regulates surface expression of delta-opioid receptors and opioid analgesia. Cell 122:619-631. (Pubitemid 41191159)
18. Guarna M, Bartolini A, Ghelardini C, Galeotti N, Bracci L, Stefano GB, and Bianchi E (2003) Anti-μ opioid antiserum against the third external loop of the cloned μ-opioid receptor acts as a μ receptor neutral antagonist. Brain Res Mol Brain Res 119:100-110. (Pubitemid 37324802)
19. Guo J, Wu Y, Zhang W, Zhao J, Devi LA, Pei G, and Ma L (2000) Identification of G protein-coupled receptor kinase 2 phosphorylation sites responsible for agoniststimulated μ-opioid receptor phosphorylation. Mol Pharmacol 58:1050-1056. (Pubitemid 30800796)
20. Gurevich VV and Gurevich EV (2008) GPCR monomers and oligomers: it takes all kinds. Trends Neurosci 31:74-81.
21. Hague C, Uberti MA, Chen Z, Hall RA, and Minneman KP (2004) Cell surface expression of α-1D-adrenergic receptors is controlled by heterodimerization with α-1B-adrenergic receptors. J Biol Chem 279:15541-15549. (Pubitemid 38618955)
22. Jordan BA and Devi LA (1999) G-protein-coupled receptor heterodimerization modulates receptor function. Nature 399:697-700.
23. Kim H, Neubert JK, San Miguel A, Xu K, Krishnaraju RK, Iadarola MJ, Goldman D, and Dionne RA (2004) Genetic influence on variability in human acute experimental pain sensitivity associated with gender, ethnicity and psychological temperament. Pain 109:488-496. (Pubitemid 38638726)
24. Law PY, Erickson-Herbrandson LJ, Zha QQ, Solberg J, Chu J, Sarre A, and Loh HH (2005) Heterodimerization of μ- and δ-opioid receptors occurs at the cell surface only and requires receptor-G protein interactions. J Biol Chem 280:11152-11164. (Pubitemid 40418422)
25. Leskelä TT, Markkanen PM, Alahuhta IA, Tuusa JT, and Petäjä-Repo UE (2009) Phe27Cys polymorphism alters the maturation and subcellular localization of the human δ opioid receptor. Traffic 10:116-129.
26. B receptor heterodimerization. Neuron 27:97-106.
27. Matthes HW, Maldonado R, Simonin F, Valverde O, Slowe S, Kitchen I, Befort K, Dierich A, Le Meur M, Dollé P, et al. (1996) Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ opioid-receptor gene. Nature 383:819-823. (Pubitemid 26372664)
28. Petäjä-Repo UE, Hogue M, Bhalla S, Laperriére A, Morello JP, and Bouvier M(2002) Ligands act as pharmacological chaperones and increase the efficiency of δ opioid receptor maturation. EMBO J 21:1628-1637. (Pubitemid 34614619)
29. 2+ channels in transfected rat pituitary cells. J Pharmacol Exp Ther 295:552-562. (Pubitemid 30780986)
30. Rau KK, Caudle RM, Cooper BY, and Johnson RD (2005) Diverse immunocytochemical expression of opioid receptors in electrophysiologically defined cells of rat dorsal root ganglia. J Chem Neuroanat 29:255-264. (Pubitemid 40775812)
31. Rees DC (1992) Chemical structures and biological activities of nonpeptide selective κ opioid ligands. Prog Med Chem 29:109-139.
32. Rozenfeld R and Devi LA (2007) Receptor heterodimerization leads to a switch in signaling: β-arrestin2-mediated ERK activation by μ-δ opioid receptor heterodimers. FASEB J 21:2455-2465.
33. Rusin KI and Moises HC (1995) μ-Opioid receptor activation reduces multiple components of high-threshold calcium current in rat sensory neurons. J Neurosci 15:4315-4327.
34. Scherrer G, Befort K, Contet C, Becker J, Matifas A, and Kieffer BL (2004) The δ agonists DPDPE and deltorphin II recruit predominantly μ receptors to produce thermal analgesia: a parallel study of μ, δ and combinatorial opioid receptor knockout mice. Eur J Neurosci 19:2239-2248. (Pubitemid 38582212)
35. Simonin F, Valverde O, Smadja C, Slowe S, Kitchen I, Dierich A, Le Meur M, Roques BP, Maldonado R, and Kieffer BL (1998) Disruption of the κ-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective κ-agonist U-50,488H and attenuates morphine withdrawal. EMBO J 17:886-897. (Pubitemid 28077643)
36. Terrillon S, Durroux T, Mouillac B, Breit A, Ayoub MA, Taulan M, Jockers R, Barberis C, and Bouvier M (2003) Oxytocin and vasopressin V1a and V2 receptors form constitutive homo- and heterodimers during biosynthesis. Mol Endocrinol 17:677-691. (Pubitemid 36403579)
37. Trapaidze N, Keith DE, Cvejic S, Evans CJ, and Devi LA (1996) Sequestration of the δ opioid receptor. J Biol Chem 271:29279-29285.
38. Walwyn W, Evans CJ, and Hales TG (2007) β-Arrestin2 and c-Src regulate the constitutive activity and recycling of μ opioid receptors in dorsal root ganglion neurons. J Neurosci 27:5092-5104. (Pubitemid 46741772)
39. Walwyn W, Maidment NT, Sanders M, Evans CJ, Kieffer BL, and Hales TG (2005) Induction of δ opioid receptor function by up-regulation of membrane receptors in mouse primary afferent neurons. Mol Pharmacol 68:1688-1698. (Pubitemid 41654352)
40. Walwyn WM, Keith DE Jr, Wei W, Tan AM, Xie CW, Evans CJ, Kieffer BL, and Maidment NT (2004) Functional coupling, desensitization and internalization of virally expressed μ opioid receptors in cultured dorsal root ganglion neurons from μ opioid receptor knockout mice. Neuroscience 123:111-121. (Pubitemid 37518480)
41. Williams JT, Christie MJ, and Manzoni O (2001) Cellular and synaptic adaptations mediating opioid dependence. Physiol Rev 81:299-343. (Pubitemid 32096178)
42. Zhang H, Kranzler HR, Yang BZ, Luo X, and Gelernter J (2008) The OPRD1 and OPRK1 loci in alcohol or drug dependence: OPRD1 variation modulates substance dependence risk. Mol Psychiatry 13:531-543. (Pubitemid 351556028)
43. Zhang X, Bao L, and Guan JS (2006) Role of delivery and trafficking of δ-opioid peptide receptors in opioid analgesia and tolerance. Trends Pharmacol Sci 27:324-329. (Pubitemid 44183608)
44. Zhu Y, King MA, Schuller AG, Nitsche JF, Reidl M, Elde RP, Unterwald E, Pasternak GW, and Pintar JE (1999) Retention of supraspinal δ-like analgesia and loss of morphine tolerance in δ opioid receptor knockout mice. Neuron 24:243-252. (Pubitemid 29466162)